Hemocompatible albumin-heparin coatings prepared by the layer-by-layer technique. The effect of layer ordering on thrombin inhibition and platelet adhesion

Journal of Biomedical Materials Research - Part A

Volumn 86, Issue 3, 2008, Pages 769-778

  Houska, Milan ^a   Brynda, Eduard ^a   Solovyev, Andrey ^a,c   Broučková, Adéla ^b,d   Křížová, Petra ^b   Vaníčková, Martina ^b   Dyr, Jan E ^b  

^a INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Albumin heparin coating; Hemocompatibility; Layer by layer assembly; Platelet adhesion; Thrombin inhibition

Indexed keywords

ADHESION; BLOOD SUBSTITUTES; MULTILAYERS; PLATELETS; POLYSACCHARIDES;

ALBUMIN-HEPARIN COATING; ANTITHROMBIN; CROSSLINKED; HEMOCOMPATIBILITY; LAYER ORDERING; LAYER-BY-LAYER ASSEMBLY; LAYER-BY-LAYER TECHNIQUES; MULTI-LAYER COATINGS; MULTILAYER ASSEMBLIES; PLATELET ADHESION; PLATELET ADHESIONS; SINGLE LAYERS; THROMBIN INHIBITION; TWO-LAYER COATINGS; UNDERLYING SURFACE;

COATINGS;

ALBUMIN; HEPARIN; THROMBIN;

ARTICLE; CROSS LINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LAYER BY LAYER METHOD; MATERIAL COATING; NORMAL HUMAN; PROTEIN PROTEIN INTERACTION; TECHNIQUE; THROMBOCYTE ADHESION;

ANIMALS; CATTLE; COATED MATERIALS, BIOCOMPATIBLE; CROSS-LINKING REAGENTS; HEPARIN; HUMANS; MATERIALS TESTING; PLATELET ADHESIVENESS; PLATELET COUNT; SERUM ALBUMIN, BOVINE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SWINE; THROMBIN;

EID: 49149105179     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31663     Document Type: Article

References (34)

1. Brynda E, Houska M, Vacík J, Kálal J, Novikova SP, Ilina B, Selezneva MN, Dobrova NB. Czech Patent 270919, 12 Jan. 1990 (Appl. Dec. 30, 1986) Academy of Sciences of the Czech Republic, invs. MPT A 61 L 33/00.
2. Brynda E, Houska M. Ordered multilayer assemblies: Albumin/heparin for biocompatible coatings and monoclonal antibodies for optical immunosensors. In: Lvov Y, Möhwald H, editors. Protein Architecture: Interfacing Molecular Assemblies and Immobilization Technology. New York: Marcel Dekker; 2000. p 251-286.
3. Decher G. Science 1997;277:1232.
4. Decher G, Schlenoff JB, editors. Multilayer Thin Films - Sequential Assembly of Nanocomposite Materials. Weinheim: Wiley-VCH; 2002.
5. Bertrand P, Jonas A, Laschewsky A, Legras R. Ultrathin polymer coatings by complexation of polyelectrolytes at interfaces: suitable materials, structure and properties. Macromol Rapid Commun 2000;21:319-348.
6. Lvov Y, Möhwald H, editors. Protein Architecture: Interfacing Molecular Assemblies and Immobilization Technology. New York: Marcel Dekker; 2000.
7. Brynda E, Houska M, Jiroušková M, Dyr JE. Albumin and heparin multilayer coatings for blood-contacting medical devices. J Biomed Mater Res 2000;51:249-257.
8. Brynda E, Homola J, Houska M, Pfeifer P, Skvor J. Antibody networks for surface plasmon resonance immunosensors. Sensors Actuators B 1999;54:132-144.
9. 2-microglobulin by grating coupler immunosensor with three-dimensional antibody networks. Biosens Bioelectron 1999;14:363-367.
10. Brynda E, Houska M, Wikerstal A, Brandenburg A. Optical biosensors for real-time measurement of analytes in blood. Biosens Bioelectron 2002;17:665-669.
11. Brynda E, Houska M, Pientka Z, Pachernik J, Dvorak P. Material surface modification with organized multilayer assemblies of biological macromolecules. Eur Cells Mater J Suppl 2004;1:20.
12. Houska M, Brynda E. Interactions of proteins with polyelectrolytes at solid/liquid interfaces: Sequential adsorption of albumin and heparin. J Colloid Interface Sci 1997;188:243-270.
13. Larm O, Larsson R, Olsson P. Surface immobilized heparin. In: Lane DA, Lindahl U, editors. Heparin, Chemical and Biological Properties, Clinical Applications. London: Edward Arnold; 1989. p 597-608.
14. Lane DA, Lindahl U, editors. Heparin, Chemical and Biological Properties, Clinical Applications. London: Edward Arnold; 1989.
15. Day JRS, Landis RC, Taylor KM. Heparin is much more than just an anticoagulant. J Cardiovasc Vasc Anesthesiol 2004;18:93-100.
16. von Segesser LK. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass. J Thorac Cardiovasc Surg 2001;121:200-201.
17. Bannan S, Danby A, Cowan D, Ashraf S, Martin PG. Low heparinization with heparin-bonded bypass circuits: Is it a safe strategy? Ann Thorac Surg 1997;63:663-668.
18. Nakajima T, Kawazoe K, Ishibashi K, Kubota Y, Sasaki T, Izumoto H, Nikatori T. Reduction of heparin dose is not beneficial to platelet function. Ann Thorac Surg 2000;70:196-190.
19. Johnell M, Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg 2002;124:321-332.
20. Wendel HP, Ziemer G. Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-350.
21. Gupta V, Aravamuthan BR, Baskerville S, Smith SK, Gupta V, Lauer MA, Fischeil TA. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. J Invasive Cardiol 2004;16:304-310.
22. Andersson J, Sanchez J, Ekhdal KN, Elgue G, Nilsson B, Larsson R. Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. J Biomed Mater Res A 2003;67:459-466.
23. Salzman E, Merrill EW, Kent K. Interaction of blood with artificial surfaces. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Hemostasis and Thrombosis. New York: Churchill Livingstone; 1994. p 1469-1485.
24. Brynda E, Houska M. Multiple alternating molecular layers of albumin and heparin on solid surfaces. J Colloid Interface Sci 1996;183:18-25.
25. Houska M, Brynda E, Kálal J. Protein-surface interactions studied by infrared spectroscopy. Makromol Chem Suppl 1985;9:103-106.
26. Chandler WL, Solomon DD, Hu CB, Schmer G. Estimation of surface-bound heparin activity: A comparison of methods. J Biomed Mater Res 1988;22:497-508.
27. Houska M, Brynda E, Bohatá K. The effect of polyelectrolyte chain length on layer-by-layer protein/polyelectrolyte assembly - An experimental study. J Colloid Interface Sci 2004;273:140-147.
28. Sperling C, Houska M, Brynda E, Streller U, Werner C. In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique. J Biomed Mater Res A 2007;76:681-689.
29. van Delden CJ, Engbers GHM, Feijen J. The effect of protein adsorption on the anticoagulant activity of surface immobilized heparin. J Biomater Sci Polym Ed 1996;17:727-740.
30. Nojiri C, Kido T, Sugiyma T, Horiuchi K, Kijima T, Hagiwara K, Kuribayashi E, Nogawa A, Ogiwara K, Akutsu T. Can heparin immobilized surfaces maintain nonthrombogenic activity during in-vivo long-term implantation? ASAIO J 1996;42:M468-M475.
31. Kocsis JF, Llanos G, Holmer E. Heparin-coated stents. J Long-Term Eff Med Implants 2000;10:19-45.
32. Amiji M, Park H, Park K. Study of prevention of surface induced platelet activation by albumin coating. J Biomater Sci Polym Ed 1992;3:375-388.
33. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. The effect of albumin priming solution on platelet activation during experimental long-term perfusion. Perfusion 1998;13:187-191.
34. Bos GW, Scharenborg NM, Poot AA, Engbers GH, Beugeling T, van Aken WC, Feijen J. Blood compatibility of surfaces with immobilized albumin-heparin conjugate and effect of endothelial cell seeding on platelet adhesion. J Biomed Mater Res 1999;47:279-291.